These seemingly contrasting data for SEMA3G may be explained by the high molecular heterogeneity of GBM cell lines and by the fact that high-CHD7-expressing cells specifically correspond to cells not expressing CD133, a marker of brain tumor-initiating cells. Here, SEMA3G is linked to glioblastoma.